Table 4 Cut-off values of SUA/Cr to predict insulin resistance, β cell dysfunction, and MetS risk
Cut-off value | AUC | P-value | Sensitivity(%) | Specificity(%) | |
|---|---|---|---|---|---|
1st tertile | |||||
Insulin resistance (HOMA-IR) | 4.9533 | 0.524 | 0.017 | 43.4 | 61.4 |
β cell dysfunction (HOMA-β) | 4.8246 | 0.517 | 0.044 | 34.3 | 69.4 |
Incidence of MetS | 5.4795 | 0.503 | 0.815 | 31.7 | 71.9 |
2nd tertile | |||||
Insulin resistance (HOMA-IR) | 6.3393 | 0.528 | 0.003 | 65.2 | 40.8 |
β cell dysfunction (HOMA-β) | 6.7925 | 0.512 | 0.161 | 25.0 | 79.0 |
Incidence of MetS | 5.4795 | 0.503 | 0.815 | 31.7 | 71.9 |
3rd tertile | |||||
Insulin resistance (HOMA-IR) | 8.2716 | 0.574 | < 0.001 | 47.5 | 64.3 |
β cell dysfunction (HOMA-β) | 8.8710 | 0.526 | 0.002 | 25.4 | 79.1 |
Incidence of MetS | 7.9762 | 0.558 | < 0.001 | 57.4 | 52.3 |
Total | |||||
Insulin resistance (HOMA-IR) | 7.0175 | 0.593 | < 0.001 | 47.0 | 68.0 |
β cell dysfunction (HOMA-β) | 6.7925 | 0.520 | < 0.001 | 43.3 | 60.9 |
Incidence of MetS | 6.9369 | 0.590 | < 0.001 | 49.2 | 64.8 |